# Effects of Rimonabant on Walking Abilities in Incomplete Spinal Cord Injury

> **NCT05398913** · PHASE1,PHASE2 · COMPLETED · sponsor: **Hospital Nacional de Parapléjicos de Toledo** · enrollment: 8 (actual)

## Conditions studied

- Spinal Cord Injuries

## Interventions

- **DRUG:** Rimonabant

## Key facts

- **NCT ID:** NCT05398913
- **Lead sponsor:** Hospital Nacional de Parapléjicos de Toledo
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-12
- **Primary completion:** 2022-06-07
- **Final completion:** 2022-06-07
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2022-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05398913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05398913, "Effects of Rimonabant on Walking Abilities in Incomplete Spinal Cord Injury". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05398913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*